Pharmaceutical - Women's Health, Valeant Pharmaceuticals


Popular Filters

Regulatory briefs: Gilead files sofosbuvir; FDA approves Diclegis; Health Canada clears Dysport


US biotech firm Gilead Sciences (Nasdaq: GILD) says it has submitted a New Drug Application to the US…

Anti-viralsBiotechnologyDermatologicalsDiclegisDuchesnayDysportGilead SciencesIpsenNorth AmericaPharmaceuticalRegulationsofosbuvirValeant PharmaceuticalsWomen's Health

Depomed to file NDA for Serada; with Valeant sues Watson over Glumetza


US drugmaker Depomed (Nasdaq: DEPO) says that it has completed a Type B pre-New Drug Application meeting…

DepomedDiabetesGenericsGlumetzaNorth AmericaPatentsPharmaceuticalRegulationResearchSeradaValeant PharmaceuticalsWatson PharmaceuticalsWomen's Health

Back to top